Research Article

The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal Cancers

Table 1

Descriptive statistics of the pancreatic cancer (PC) and non-small cell lung cancer (NSCLC) patient samples.
(a) Categorical variables

VariablePC (%)NSCLC (%)

Gender
 Men53.0%63.4%
 Women47.0%36.6%
Radiotherapy13.4%69.0%
Chemotherapy73.3%76.0%
Surgery40.1%10.0%
Stage
 Stage 111.3%
 Stage 27.0%
 Stage 321.1%
 Stage 460.6%

(b) Continuous variables

VariablePC
Mean (SD)
NSCLC
Mean (SD)

Age (years)66.2 (11.8)62.5 (11.5)
HRV (RMSSD)27.4 (20.5)21.6 (24.0)
CRP4.7 (18.8)43.1 (63.3)

PC: pancreatic cancer; NCSLC: non-small cell lung cancer; HRV: heart rate variability; RMSSD: root mean square of successive differences; CRP: C-reactive protein.